Table 3: Fasting Laboratory and Other Characteristics of Male Patients with Type 2 Diabetes Mellitus at 3 Months

Group A (n=26) Group B (n=15) p
Weight (kg) 76.1±14.4 77.5±9.4 ns
BMI (kg/m2) 26.9±4.2 27.7±3.3 ns
Waist circumference (cm) 96.7±12.4 98.1±8.3 ns
Body fat (%) 34.5±13 37.5±6.8 ns
SBP (mmHg) 137.7±18.2 133.7±12.9 ns
DBP(mmHg) 76.9±12.1 76.7±10.5 ns
WCC (x103/µl) 6782±2174 6953±1472 ns
Uric acid (mg/dl) 5.7±1.5 5.7±0.9 ns
TC (mg/dl) 190±49 173±28 ns
TG (mg/dl) 129±58 136±53 ns
HDL-C (mg/dl) 48±10 48±11 ns
LDL-C (mg/dl) 116±40 97±23 ns
AST (u/l) 19±5 21±9 ns
ALT(u/l)) 19±7 23±11 ns
CK (u/l) 106±60 99±86 ns
Gamma-GT (u/l) 30
(10-75)
17
(10-475)
ns
Glucose (mg/dl) 151±51 123±31 ns
HbA1c (%) 7±1.6 5.8±0.9 N/A
Cr (mg/dl) 0.9±0.3 0.9±0.2 ns
Leptin (ng/ml) 10.4±7.7 6.7±4.3 ns
Adiponectin (µg/ml) 15±11.6 11.7±7.3 ns
Ghrelin (pg/ml) 933±574 801±227 ns
NPY (pmol/L) 111.7±26.3 133.4±27.6 0.017
MDRD eGFR (mL/min/1.73m2) 87.1±24.7 95.5±27.1 ns
Cockroft-Gault creatinine clearance (mL/min) 84.7±32.9 90.8±25.5 ns

For abbreviations see Table 1.